| Brain-Gut-Microbiota Axis in Alzheimer's Disease |
76 |
| Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use |
33 |
| Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review |
22 |
| Sex-Gender Differences in Irritable Bowel Syndrome |
22 |
| Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation |
19 |
| The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger? |
16 |
| Mechanisms of Stress-induced Visceral Pain |
14 |
| Gastroparesis and Functional Dyspepsia: A Blurring Distinction of Pathophysiology and Treatment |
14 |
| Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases |
12 |
| Success and Complication Rates After Sacral Neuromodulation for Fecal Incontinence and Constipation: A Single-center Follow-up Study |
11 |
| Role of the Duodenum in the Pathogenesis of Functional Dyspepsia: A Paradigm Shift |
10 |
| Understanding Neurogastroenterology From Neuroimaging Perspective: A Comprehensive Review of Functional and Structural Brain Imaging in Functional Gastrointestinal Disorders |
10 |
| Bifidobacterium longum and Lactobacillus helveticus Synergistically Suppress Stress-related Visceral Hypersensitivity Through Hypothalamic-Pituitary-Adrenal Axis Modulation |
9 |
| Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders |
9 |
| Relation of Enteric alpha-Synuclein to Gastrointestinal Dysfunction in Patients With Parkinson's Disease and in Neurologically Intact Subjects |
9 |
| Second Asian Consensus on Irritable Bowel Syndrome |
9 |
| Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker |
8 |
| Association Between Anxiety and Depression and Gastroesophageal Reflux Disease: Results From a Large Cross-sectional Study |
8 |
| Expression of Toll-like Receptors, Pro and Anti-inflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis |
7 |
| Neuromodulation via Interferential Electrical Stimulation as a Novel Therapy in Gastrointestinal Motility Disorders |
7 |
| Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation |
7 |
| Self-reported Sleep Impairment in Functional Dyspepsia and Irritable Bowel Syndrome |
7 |
| 200 mL Rapid Drink Challenge During High-resolution Manometry Best Predicts Objective Esophagogastric junction Obstruction and Correlates With Symptom Severity |
7 |
| Use of Dietary Management in Irritable Bowel Syndrome: Results of a Survey of Over 1500 United States Gastroenterologists |
6 |
| Prevalence and Risk Factors of Functional Dyspepsia in Health Check-up Population: A Nationwide Multicenter Prospective Study |
6 |
| MicroRNA-200a Targets Cannabinoid Receptor 1 and Serotonin Transporter to Increase Visceral Hyperalgesia in Diarrhea-predominant Irritable Bowel Syndrome Rats |
6 |
| High Prevalence of Slow Transit Constipation in Patients With Gastroparesis |
6 |
| High-resolution Manometry Findings During Solid Swallows Correlate With Delayed Reflux Clearance and Acid Exposure Time in Non-erosive Reflux Disease Patients |
5 |
| Control of Motility in the Internal Anal Sphincter |
5 |
| Is It Useful to Administer Probiotics Together With Proton Pump Inhibitors in Children With Gastroesophageal Reflux? |
5 |
| Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition |
5 |
| Chronic Cough Is Associated With Long Breaks in Esophageal Peristaltic Integrity on High-resolution Manometry |
5 |
| The Protective Effect of Melissa officinalis L. in Visceral Hypersensitivity in Rat Using 2 Models of Acid-induced Colitis and Stress-induced Irritable Bowel Syndrome: A Possible Role of Nitric Oxide Pathway |
5 |
| Five-fold Gastrointestinal Electrical Stimulation With Electromyography-based Activity Analysis: Towards Multilocular Theranostic Intestinal Implants |
5 |
| Cultural Factors Influencing Functional Gastrointestinal Disorders in the East |
5 |
| Abnormal Gastroesophageal Flap Valve Is Associated With High Gastresophageal Reflux Disease Questionnaire Score and the Severity of Gastroesophageal Reflux Disease in Vietnamese Patients With Upper Gastrointestinal Symptoms |
4 |
| Esophageal Motor Disorders Are a Strong and Independant Associated Factor of Barrett's Esophagus |
4 |
| Combined Multichannel Intraluminal Impedance and High-resolution Manometry Improves Detection of Clinically Relevant Esophagogastric Junction Outflow Obstruction |
4 |
| Functional Chronic Constipation: Rome III Criteria Versus Rome IV Criteria |
4 |
| Quantitative Analysis of Distribution of the Gastrointestinal Tract Eosinophils in Childhood Functional Abdominal Pain Disorders |
4 |
| Influence of Age and Body Mass Index on Total and Segmental Colonic Transit Times in Constipated Subjects |
4 |
| High-resolution Mapping of Hyperglycemia-induced Gastric Slow Wave Dysrhythmias |
3 |
| Colonic Transit Disorder Mediated by Downregulation of Interstitial Cells of Cajal/Anoctamin-1 in Dextran Sodium Sulfate-induced Colitis Mice |
3 |
| Esophageal Motor Dysfunctions in Gastroesophageal Reflux Disease and Therapeutic Perspectives |
3 |
| Improving High-resolution Impedance Manometry Using Novel Viscous and Super-viscous Substrates in the Supine and Upright Positions: A Pilot Study |
3 |
| Aloe vera Is Effective and Safe in Short-term Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis |
3 |
| Defective Conduction of Anorectal Afferents Is a Very Prevalent Pathophysioloical Factor Associated to Fecal Incontinence in Women |
3 |
| Multicenter Prospective Study of Laparoscopic Nissen Fundoplication for Gastroesophageal Reflux Disease in Korea |
3 |
| Dietary Habits and Abdominal Pain-related Functional Gastrointestinal Disorders: A School-based, Cross-sectional Analysis in Greek Children and Adolescents |
3 |
| Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective |
3 |
